Back
BNY Mellon Ultra Short Income ETF Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
45
BKUI
BNY Mellon Ultra Short Income ETF
Last Price:
$49.88
Seasonality Move:
0.14%
Sell
43
VKTX
Viking Therapeutics, Inc.
Last Price:
$35.15
Seasonality Move:
33.2%
Sell
45
BNY Mellon Ultra Short Income ETF (BKUI)
is a Sell
Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?
-
The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.89. The Score for BKUI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BKUI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $35.19. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BKUI Stock Price Chart
What is BNY Mellon Ultra Short Income ETF's stock price today?
-
The BNY Mellon Ultra Short Income ETF share price today is $49.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKUI is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $35.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
BKUI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 61.1 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.8 - 49.88) | Buy |
| Bollinger Bands (100): | (49.78 - 49.9) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.5 | Buy |
| Relative Strength Index (14 RSI): | 46.62 | Sell |
| Chaikin Money Flow: | 1155865 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.66 - 37.84) | Sell |
| Bollinger Bands (100): | (27.5 - 37.84) | Buy |
BKUI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.85 | Buy |
| 20-day SMA: | 49.84 | Buy |
| 50-day SMA: | 49.85 | Buy |
| 200-day SMA: | 49.79 | Buy |
| 8-day EMA: | 49.85 | Buy |
| 20-day EMA: | 49.84 | Buy |
| 50-day EMA: | 49.84 | Buy |
| 200-day EMA: | 49.8 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.89 | Sell |
| 20-day SMA: | 36.04 | Sell |
| 50-day SMA: | 35.96 | Sell |
| 200-day SMA: | 30.18 | Buy |
| 8-day EMA: | 18.3 | Buy |
| 20-day EMA: | 8.95 | Buy |
| 50-day EMA: | 3.9 | Buy |
| 200-day EMA: | 1.02 | Buy |
BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
BNY Mellon Ultra Short Income ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||